Understanding Radioligand Therapy: A New Era of Precision Cancer Treatment
Radioligand therapy (RLT) is one of the most exciting advances in precision cancer treatment. By combining a targeting molecule with a small amount of radiation, RLT delivers treatment directly to cancer cells while minimizing damage to surrounding healthy tissue. For men with advanced prostate cancer, PSMA-targeted radioligand therapy has become an important option for those who meet specific eligibility criteria.
If you'd like to learn more about this innovative treatment, the Cancer Support Community has created an excellent, easy-to-understand resource that explains how radioligand therapy works, who may benefit, what to expect during treatment, possible side effects, and the important role of PET imaging in determining eligibility. Their guide also includes practical tips for patients and caregivers, as well as links to additional support resources.
We’d like to thank the Cancer Support Community and Gilda’s Club for developing and sharing this outstanding educational resource. Their commitment to helping patients and families better understand cancer treatments is an invaluable service to the cancer community.